The Scientific Advisory Council is a distinguished body of expert scientists from 12 countries who voluntarily guide the development of the Institute’s research programs, helping to shape the fields of immunology and cancer immunology.
The Council includes five Nobel Prize winners, 29 members of the National Academy of Sciences, and 23 members of the Academy of Cancer Immunology. A universally respected authority, the Council provides all research funding recommendations to the Institute — from predoctoral training awards to grants for clinical trials — and sets the agendas for CRI-sponsored international symposia.
DIRECTOR
Lloyd J. Old, M.D. 2,3
Ludwig Institute for Cancer Research
New York, New York
ASSOCIATE DIRECTORS
James P. Allison, Ph.D.2,3,4
Memorial Sloan-Kettering Cancer Center
New York, New York
Glenn Dranoff, M.D.3
Dana-Farber Cancer Institute
Boston, Massachusetts
Carl F. Nathan, M.D.3,4
Weill Medical College of Cornell University
New York, New York
Herbert F. Oettgen, M.D.3
Memorial Sloan-Kettering Cancer Center
New York, New York
Benvenuto G. Pernis, M.D.
Columbia University
College of Physicians & Surgeons
New York, New York
Ellen Puré, Ph.D.4
The Wistar Institute
Philadelphia, Pennsylvania;
and Ludwig Institute for Cancer Research
New York, New York
Robert D. Schreiber, Ph.D.3,4,5
Washington University School of Medicine
St. Louis, Missouri
MEMBERS
Garry I. Abelev, Ph.D.3
Russian Cancer Research Center
Moscow, Russia
Frederick W. Alt, Ph.D. 2,4
Harvard Medical School,
Immune Disease Institute
Boston, Massachusetts
Richard Axel, M.D.1,2
Columbia University
College of Physicians & Surgeons
New York, New York
Baruj Benacerraf, M.D.1,2
Dana-Farber Cancer Institute
Boston, Massachusetts
Sir Walter F. Bodmer, Ph.D., F.R.S.2
Hertford College
Oxford, England
Thierry Boon, Ph.D.2,3
Ludwig Institute for Cancer Research
Brussels, Belgium
Harvey Cantor, M.D.2
Dana-Farber Cancer Institute
Boston, Massachusetts
Jean-Charles Cerottini, M.D. (Retired)3
Ludwig Institute for Cancer Research
Lausanne, Switzerland
Max D. Cooper, M.D.2,4
Emory University
Atlanta, Georgia
Peter Cresswell, Ph.D.2,4
Yale University School of Medicine
New Haven, Connecticut
Jean Dausset, M.D.1,2
Foundation Jean Dausset - CEPH
Paris, France
Michael L. Dustin, Ph.D.4
New York University School of Medicine
New York, New York
Emil Frei III, M.D.
Dana-Farber Cancer Institute
Boston, Massachusetts
Laurie H. Glimcher, M.D.2,4,5
Harvard School of Public Health
Boston, Massachusetts
Gideon Goldstein, M.D., Ph.D.
Thymon, LLC
Short Hills, New Jersey
Philip D. Greenberg, M.D.3,4
University of Washington School of Medicine
and Fred Hutchinson Cancer Research Center
Seattle, Washington
Jordan U. Gutterman, M.D.
The University of Texas M.D. Anderson Cancer Center
Houston, Texas
Sen-itiroh Hakomori, M.D., Ph.D.2
University of Washington School of Medicine
Seattle, Washington
Karl Erik Hellström, M.D., Ph.D.
University of Washington
Seattle, Washington
Richard J. Hodes, M.D.
National Institute on Aging
Bethesda, Maryland
Alan N. Houghton, M.D.3
Memorial Sloan-Kettering Cancer Center
New York, New York
John M. Kirkwood, M.D.
Pittsburgh Cancer Institute
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
George Klein, M.D., D.Sc.2,3
Karolinska Institute
Stockholm, Sweden
Alexander Knuth, M.D.3,5
University Hospital Zurich
Zurich, Switzerland
John Kuriyan, Ph.D.2
University of California, Berkeley
Berkeley, California
Lewis L. Lanier, Ph.D.5
University of California, San Francisco
San Francisco, California
Richard A. Lerner, M.D.2
The Scripps Research Institute
La Jolla, California
Dan R. Littman, M.D., Ph.D.2
Memorial Sloan-Kettering Cancer Center
New York, New York
Tak W. Mak, Ph.D., D.Sc., FRSC2,4
Advanced Medical Discovery Institute
University Health Network
Toronto, Canada
Philippa C. Marrack, Ph.D.2
National Jewish Medical and Research Center and
University of Colorado Health Sciences Center, HHMI
Denver, Colorado
Hugh O. McDevitt, M.D.2
Stanford University School of Medicine
Stanford, California
Ira Mellman, Ph.D.5
Yale University School of Medicine
New Haven, Connecticut; and
Genentech, Inc.
S. San Francisco, California
Malcolm A.S. Moore, D.Phil.
Memorial Sloan-Kettering Cancer Center
New York, New York
Donald L. Morton, M.D.
John Wayne Cancer Institute
Santa Monica, California
Lee Nadler, M.D.
Dana-Farber Cancer Institute
Boston, Massachusetts
Stanley G. Nathenson, M.D.2,4
Albert Einstein College of Medicine
Bronx, New York
Sir Gustav Nossal, M.D., Ph.D., F.R.S.2
The University of Melbourne
Melbourne, Australia
Victor Nussenzweig, M.D., Ph.D.
New York University School of Medicine
New York, New York
Drew M. Pardoll, M.D., Ph.D.3,4
The Johns Hopkins University School of Medicine
Baltimore, Maryland
William E. Paul, M.D.2
National Institutes of Health
Bethesda, Maryland
Klaus Rajewsky, M.D.2,3
Harvard Medical School
Immune Disease Institute
Boston, Massachusetts
Anjana Rao, Ph.D.2,4
Harvard Medical School
Immune Disease Institute
Boston, Massachusetts
Jeffrey V. Ravetch, M.D., Ph.D.2,4
The Rockefeller University
New York, New York
Gert Riethmüller, M.D.3
University of Munich
Munich, Germany
Alexander Rudensky, Ph.D.4
University of Washington School of Medicine
Seattle, Washington
Bijan Safai, M.D., D.Sc.
New York Medical College
Valhalla, New York
Lawrence E. Samelson, M.D.4
National Cancer Institute
Bethesda, Maryland
Stuart F. Schlossman, M.D.2,3
Dana-Farber Cancer Institute
Boston, Massachusetts
Hans Schreiber, M.D., Ph.D.3,4
University of Chicago
Chicago, Illinois
Gregory W. Siskind, M.D. (Retired)
Weill Medical College of Cornell University
New York, New York
Pramod K. Srivastava, Ph.D.3
University of Connecticut School of Medicine
Farmington, Connecticut
Ursula Storb, M.D.4
University of Chicago
Chicago, Illinois
Zongtang Sun, M.D.
Cancer Institute
Chinese Academy of Medical Sciences
Beijing, People’s Republic of China
Tomio Tada, M.D., D.M.S.
Science University of Tokyo
Research Institute for Biological Sciences
Tokyo, Japan
Toshitada Takahashi, M.D.3
Aichi Cancer Center Research Institute
Nagoya, Japan
Susumu Tonegawa, Ph.D.1,2
Massachusetts Institute of Technology
Cambridge, Massachusetts
Giorgio Trinchieri, M.D.3,4,5
National Cancer Institute
National Institutes of Health
Frederick, Maryland
Ulrich H. von Andrian, M.D.4
Harvard Medical School
Immune Disease Institute
Boston, Massachusetts
David W. Weiss, Ph.D., D.Phil.
The Hebrew University
Hadassah Medical School
Jerusalem, Israel
Jedd D. Wolchok, M.D., Ph.D.
Memorial Sloan-Kettering Cancer Center
New York, New York
Hao Wu, Ph.D.4
Weill Medical College of Cornell University
New York, New York
Rolf M. Zinkernagel, M.D., Ph.D.1,2,3
University of Zurich
Zurich, Switzerland
HONORARY MEMBERS
Robert W. Baldwin, Ph.D., F.R.C. Path.
University of Nottingham
Nottingham, England
Isaac Djerassi, M.D.
Mercy Catholic Medical Center
Philadelphia, Pennsylvania
James F. Holland, M.D.
Mount Sinai School of Medicine
New York, New York
Georges Mathé, M.D.
Institute of Oncology and Immunogenetics
Villejuif, France
Richmond T. Prehn, M.D. (Retired)3
University of Washington
Seattle, Washington
Bernard Roizman, Sc.D.2
University of Chicago
Chicago, Illinois
Legend:
1 Nobel Laureate
2 Member, National Academy of Sciences
3 Member, Academy of Cancer Immunology
4 Member, Fellowship Review Committee
5 Member, Investigator Award and Predoctoral Program Review Committee